Search Within


Applied Filters:
Showing 1-1 of 1 result for "200-066-2" within Papers
Craig W Hendrix et al.
AIDS research and human retroviruses, 32(1), 32-43 (2015-09-29)
Oral preexposure prophylaxis (PrEP) trials report disparate efficacy attributed to variable adherence. HPTN 066 was conducted to establish objective, quantitative benchmarks for discrete, regular levels of adherence using directly observed dosing of tenofovir (TFV) disoproxil fumarate (TDF)/emtricitabine (FTC). Healthy, HIV-uninfected
Page 1 of 1